HSR23-108: Physician Preferences on Biomarker Testing in Newly-Diagnosed Metastatic NSCLC Patients Who Had Insufficient Tumor Tissue

Anne Shah,Jon Apple, Gabriela Burgos, Josh Lankin, Jesse Cohn,Janelle Cambron-Mellott,Emily Mulvihill

Journal of the National Comprehensive Cancer Network（2023）

引用 0|浏览0

暂无评分

摘要

"HSR23-108: Physician Preferences on Biomarker Testing in Newly-Diagnosed Metastatic NSCLC Patients Who Had Insufficient Tumor Tissue" published on 31 Mar 2023 by National Comprehensive Cancer Network.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要